氨氯地平联合复方阿米洛利或替米沙坦对高血压患者降压疗效的相关临床因素分析

来源 :第二届中国高血压大会暨中国医师协会高血压专业委员会年会 | 被引量 : 0次 | 上传用户：xingxing7978

【摘要】

：

目的探讨以氨氯地平为基础的联合降压治疗方案不能有效控制高血压患者血压的相关临床影响因素.方法 2008 年3 月至10 月在浙江省11 家医疗机构入选50～79 岁伴心血管病危险因素的高血压患者700 例,采用多中心、随机、开放、对照的临床试验方法,随机分为氨氯地平加复方阿米洛利组(A 组,354 例)或氨氯地平加替米沙坦组(B 组,346 例),进行早期联合药物降压治疗,随访观察8 周.

【作者】

：

俞蔚韩丽雅金宏义唐新华王文徐小玲章一丰方顺元周爱芬王苏英傅胜文

【机构】

：

浙江医院高血压中心,浙江省心脑血管病防治研究中心温州市第二人民医院

【出处】

：

第二届中国高血压大会暨中国医师协会高血压专业委员会年会

【发表日期】

：

2012年9期

【关键词】

：

Hypertension Drug therapy Combination Clinical factor

下载到本地 , 更方便阅读

下载此文赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

其他文献

Associations between genetic variations in the FURINgene and hypertension

Background Hypertension is a complex disease influenced by multiple genetic and environmental factors.The Kazakh ethnic group is characterized by a relatively high prevalence of hypertension.Previous

会议

association studyhypertensionFURINsingle nucleotide polymorphismKazakh

AT2受体通过NO/cGMP/Sp1途径降低肾脏近曲小管AT1受体表达与功能

目的肾素-血管紧张素-醛固酮系统(RAS)是机体重要的体液调节系统,在血压调控、水盐代谢中发挥了重要作用.血管紧张素Ⅱ(Ang Ⅱ)是RAS系统的重要活性肽,在肾脏中主要通过AT1和AT2受体发挥作用.以往研究认为AngⅡ在肾脏的促进尿钠潴留等生物学效应主要通过AT1受体介导.

会议

AT2 受体AT1 受体肾脏近曲小管上皮细胞钠排泄血压

Composition identification of Salvia heteroglycan and testing of its inhibiting myocytes cell death

A four-factor,three-level factorial design was used to evaluate the effects ofthe following fac-tors on the extraction efficiency:extraction temperature (A),extraction time (B),particle size (C)and ra

会议

Controlled and Cardiac-Restricted Overexpression of the Arginine Vasopressin V1A Receptor Causes Rev

Background Arg8]-vasopressin (AVP) activates 3 G-protein–coupled receptors: V1A,V2,and V1B.The AVP-V1A receptor is the primary AVP receptor in the heart； however,its role in cardiac homeostasis is con

会议

vasopressin receptorsV1A vasopressin receptorssignal transductionheart failur

D型人格与社会支持对糖尿病患者血糖、血压、血脂的影响

会议

Decreased Glomerular Filtration Rate is Associated with Mortality and Cardiovascular Events in Patie

Objectives It has been demonstrated that decreased GFR is associated with increased all-cause and CVD mortality,incident coronary heart disease (CHD) in general population.However,few studies reported

会议

Effect of Ginkgo Biloba Extract 50 on Immunity and Antioxidant Enzyme Activities in Ischemia Reperfu

The aim of the study was to investigate the effect of Ginkgo biloba extract50 (GBE50),a well-known natural antioxidant,against immunity and antioxidantenzyme activities in ischemia reperfusion (IR) ra

会议

myocardial ischemia-reperfusionantioxidantimmunityratGBE50

Genetic variation of NEDD4L is associated with essential hypertension in female Kazakh

Background Hypertension affects > 18.8％ of adults in China.Indeed,hypertension is the most prevalent risk factor for cardiovascular morbidity and mortality worldwide.Genetic variation is thought to co

会议

The diagnostic value of glomerular filtration rate in non-atherosclerotic renal artery stenosis

Purpose To analysis the diagnostic value of GFR measured by 99mTc-DTPA renal dynamic imaging to non-atherosclerotic renal artery stenosis (NA-RAS).Methods Case selection: The patients hospitalized in

会议

氨氯地平单用及联用依那普利对肾性高血压大鼠主动脉重塑及中膜离子泵的影响

目的观察氨氯地平单用及联用依那普利对肾血管性高血压大鼠(RHR)主动脉重塑及对其主动脉平滑肌细胞膜钠泵、钙泵活性和钠泵а1 亚单位及细胞质膜钙泵亚型1(PMCA1)mRNA表达水平的影响,探讨氨氯地平单用及联用依那普利改善动脉重塑的可能机制.

会议

高血压肾血管性钠泵钙泵平滑肌大鼠动脉重塑氨氯地平依那普利

氨氯地平联合复方阿米洛利或替米沙坦对高血压患者降压疗效的相关临床因素分析

与本文相关的学术论文